PE20142297A1 - Bioensayos con calidad controlada basados en celulas para productos nutriceuticos y medicinales - Google Patents
Bioensayos con calidad controlada basados en celulas para productos nutriceuticos y medicinalesInfo
- Publication number
- PE20142297A1 PE20142297A1 PE2014001438A PE2014001438A PE20142297A1 PE 20142297 A1 PE20142297 A1 PE 20142297A1 PE 2014001438 A PE2014001438 A PE 2014001438A PE 2014001438 A PE2014001438 A PE 2014001438A PE 20142297 A1 PE20142297 A1 PE 20142297A1
- Authority
- PE
- Peru
- Prior art keywords
- cell
- composition
- inhibition
- proliferation
- nutriceutic
- Prior art date
Links
- 238000004166 bioassay Methods 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 abstract 5
- 230000035755 proliferation Effects 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/02—Food
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
REFERIDO A UN METODO PARA DETERMINAR LA POTENCIA DE INHIBICION DEL INICIO DE LA TRADUCCION DE UNA COMPOSICION QUE TIENE UN GRADO DESCONOCIDO DE ACTIVIDAD DE INHIBICION DEL INICIO DE LA TRADUCCION QUE COMPRENDE: A) PONER EN CONTACTO UNA CELULA CON N� DE ACCESO ATCC PTA-13010 CON DICHA COMPOSICION DURANTE UN TIEMPO Y A UNA TEMPERATURA EFICAZ PARA INHIBIR LA PROLIFERACION DE DICHA CELULA; B) PONER EN CONTACTO UNA CELULA CON N� DE ACCESO ATCC PTA-13011 CON DICHA COMPOSICION DURANTE UN TIEMPO Y A UNA TEMPERATURA EFICAZ PARA INHIBIR LA PROLIFERACION DE DICHA CELULA; C) MEDIR EL NIVEL DE INHIBICION DE PROLIFERACION DE DICHA CELULA CON N� DE ACCESO ATCC PTA-13010 Y DICHA CELULA CON N� DE ACCESO ATCC PTA-13011 INDUCIDO POR DICHA COMPOSICION; D) COMPARAR EL NIVEL DE INHIBICION DE PROLIFERACION INDUCIDO POR DICHA COMPOSICION CON EL NIVEL DE INHIBICION DE PROLIFERACION INDUCIDO POR UN ESTANDAR QUE TIENE UNA CANTIDAD CONOCIDA DE DICHA ACTIVIDAD; E) IDENTIFICAR LA COMPOSICION
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261674180P | 2012-07-20 | 2012-07-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20142297A1 true PE20142297A1 (es) | 2014-12-19 |
Family
ID=48916225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2014001438A PE20142297A1 (es) | 2012-07-20 | 2013-07-22 | Bioensayos con calidad controlada basados en celulas para productos nutriceuticos y medicinales |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9952200B2 (es) |
| EP (1) | EP2820418B1 (es) |
| JP (1) | JP6200501B2 (es) |
| KR (1) | KR102136763B1 (es) |
| CN (1) | CN104641231B (es) |
| AU (1) | AU2013292266B2 (es) |
| CA (1) | CA2866175C (es) |
| CL (1) | CL2014002530A1 (es) |
| CO (1) | CO7151536A2 (es) |
| DK (1) | DK2820418T3 (es) |
| ES (1) | ES2656941T3 (es) |
| HU (1) | HUE036166T2 (es) |
| IN (1) | IN2014DN07866A (es) |
| MA (1) | MA35924B1 (es) |
| MX (1) | MX356147B (es) |
| NO (1) | NO2912013T3 (es) |
| PE (1) | PE20142297A1 (es) |
| PL (1) | PL2820418T3 (es) |
| PT (1) | PT2820418T (es) |
| RU (1) | RU2662358C2 (es) |
| WO (1) | WO2014015328A1 (es) |
| ZA (1) | ZA201406653B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107217087B (zh) * | 2016-03-22 | 2019-12-10 | 中国石油化工股份有限公司 | 迅速测量油田污水和成品油中细菌含量的方法 |
| CN115785247B (zh) * | 2022-12-22 | 2025-06-24 | 中国农业大学 | 一种猪流行性腹泻病毒抗性相关蛋白质eif2a及其相关生物材料和应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4318846A (en) | 1979-09-07 | 1982-03-09 | Syva Company | Novel ether substituted fluorescein polyamino acid compounds as fluorescers and quenchers |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4757141A (en) | 1985-08-26 | 1988-07-12 | Applied Biosystems, Incorporated | Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof |
| US5091519A (en) | 1986-05-01 | 1992-02-25 | Amoco Corporation | Nucleotide compositions with linking groups |
| US5151507A (en) | 1986-07-02 | 1992-09-29 | E. I. Du Pont De Nemours And Company | Alkynylamino-nucleotides |
| US4843155A (en) | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
| US5066580A (en) | 1988-08-31 | 1991-11-19 | Becton Dickinson And Company | Xanthene dyes that emit to the red of fluorescein |
| US5366860A (en) | 1989-09-29 | 1994-11-22 | Applied Biosystems, Inc. | Spectrally resolvable rhodamine dyes for nucleic acid sequence determination |
| US5188934A (en) | 1989-11-14 | 1993-02-23 | Applied Biosystems, Inc. | 4,7-dichlorofluorescein dyes as molecular probes |
| US5654419A (en) | 1994-02-01 | 1997-08-05 | The Regents Of The University Of California | Fluorescent labels and their use in separations |
| US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| US5847162A (en) | 1996-06-27 | 1998-12-08 | The Perkin Elmer Corporation | 4, 7-Dichlororhodamine dyes |
| US5800996A (en) | 1996-05-03 | 1998-09-01 | The Perkin Elmer Corporation | Energy transfer dyes with enchanced fluorescence |
| US6322901B1 (en) | 1997-11-13 | 2001-11-27 | Massachusetts Institute Of Technology | Highly luminescent color-selective nano-crystalline materials |
| US6207392B1 (en) | 1997-11-25 | 2001-03-27 | The Regents Of The University Of California | Semiconductor nanocrystal probes for biological applications and process for making and using such probes |
| US5990479A (en) | 1997-11-25 | 1999-11-23 | Regents Of The University Of California | Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes |
| US6426513B1 (en) | 1998-09-18 | 2002-07-30 | Massachusetts Institute Of Technology | Water-soluble thiol-capped nanocrystals |
| US6251303B1 (en) | 1998-09-18 | 2001-06-26 | Massachusetts Institute Of Technology | Water-soluble fluorescent nanocrystals |
| US6649138B2 (en) | 2000-10-13 | 2003-11-18 | Quantum Dot Corporation | Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media |
| US6576291B2 (en) | 2000-12-08 | 2003-06-10 | Massachusetts Institute Of Technology | Preparation of nanocrystallites |
| EP1409240B1 (en) | 2001-07-20 | 2012-05-09 | Life Technologies Corporation | Luminescent nanoparticles and methods for their preparation |
| WO2007008221A2 (en) * | 2004-08-10 | 2007-01-18 | President And Fellows Of Harvard College | DETECTION OF PHOSPHORYLATED eIF2α AS A DIAGNOSTIC TEST FOR EFFICIENCY AND SENSITVITY OF TRANSLATION INITIATION INHIBITORS IN THE TREATMENT OF CANCER AND OTHE R PROLIFERATIVE DISEASES |
| WO2008008333A2 (en) | 2006-07-11 | 2008-01-17 | President And Fellows Of Harvard College | Bioassays for quality control of nutriceuticals that inhibit, upregulate or otherwise modulate translation initiation |
| PE20120793A1 (es) * | 2009-04-17 | 2012-07-04 | Harvard College | Bioensayo de control de calidad para productos nutriceuticos y medicinales |
| WO2010138820A2 (en) * | 2009-05-28 | 2010-12-02 | President And Fellows Of Harvard College | N,n-diarylurea compounds and n,n'-diarylthiourea compounds as inhibitors of translation initiation |
| CN101671669B (zh) * | 2009-08-27 | 2012-05-02 | 浙江大学 | 一种肝癌靶向性基因表达元件ae及其应用 |
-
2013
- 2013-07-22 IN IN7866DEN2014 patent/IN2014DN07866A/en unknown
- 2013-07-22 MX MX2014012542A patent/MX356147B/es active IP Right Grant
- 2013-07-22 JP JP2015523300A patent/JP6200501B2/ja not_active Expired - Fee Related
- 2013-07-22 AU AU2013292266A patent/AU2013292266B2/en not_active Ceased
- 2013-07-22 PE PE2014001438A patent/PE20142297A1/es active IP Right Grant
- 2013-07-22 ES ES13745268.6T patent/ES2656941T3/es active Active
- 2013-07-22 CN CN201380031597.XA patent/CN104641231B/zh not_active Expired - Fee Related
- 2013-07-22 US US14/382,116 patent/US9952200B2/en active Active
- 2013-07-22 WO PCT/US2013/051433 patent/WO2014015328A1/en not_active Ceased
- 2013-07-22 PT PT137452686T patent/PT2820418T/pt unknown
- 2013-07-22 HU HUE13745268A patent/HUE036166T2/hu unknown
- 2013-07-22 DK DK13745268.6T patent/DK2820418T3/en active
- 2013-07-22 PL PL13745268T patent/PL2820418T3/pl unknown
- 2013-07-22 RU RU2014136408A patent/RU2662358C2/ru active
- 2013-07-22 CA CA2866175A patent/CA2866175C/en active Active
- 2013-07-22 EP EP13745268.6A patent/EP2820418B1/en active Active
- 2013-07-22 KR KR1020147026323A patent/KR102136763B1/ko not_active Expired - Fee Related
- 2013-10-25 NO NO13849263A patent/NO2912013T3/no unknown
-
2014
- 2014-09-04 MA MA37323A patent/MA35924B1/fr unknown
- 2014-09-10 ZA ZA2014/06653A patent/ZA201406653B/en unknown
- 2014-09-19 CO CO14208659A patent/CO7151536A2/es unknown
- 2014-09-24 CL CL2014002530A patent/CL2014002530A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IN2014DN07866A (es) | 2015-04-24 |
| RU2014136408A (ru) | 2016-09-10 |
| CA2866175A1 (en) | 2014-01-23 |
| WO2014015328A1 (en) | 2014-01-23 |
| ZA201406653B (en) | 2022-05-25 |
| US20150301023A1 (en) | 2015-10-22 |
| JP2015524269A (ja) | 2015-08-24 |
| US9952200B2 (en) | 2018-04-24 |
| KR20150035496A (ko) | 2015-04-06 |
| PT2820418T (pt) | 2018-02-12 |
| CO7151536A2 (es) | 2014-12-29 |
| KR102136763B1 (ko) | 2020-08-13 |
| AU2013292266B2 (en) | 2019-01-03 |
| MX2014012542A (es) | 2014-11-21 |
| MX356147B (es) | 2018-05-15 |
| ES2656941T3 (es) | 2018-03-01 |
| MA35924B1 (fr) | 2014-12-01 |
| PL2820418T3 (pl) | 2018-05-30 |
| CA2866175C (en) | 2021-04-20 |
| AU2013292266A1 (en) | 2014-09-25 |
| JP6200501B2 (ja) | 2017-09-20 |
| CN104641231B (zh) | 2016-09-07 |
| HUE036166T2 (hu) | 2018-06-28 |
| NO2912013T3 (es) | 2018-03-10 |
| DK2820418T3 (en) | 2018-02-12 |
| RU2662358C2 (ru) | 2018-07-25 |
| CN104641231A (zh) | 2015-05-20 |
| CL2014002530A1 (es) | 2015-01-09 |
| EP2820418A1 (en) | 2015-01-07 |
| EP2820418B1 (en) | 2017-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014029933A2 (pt) | aparelho para teste de eletrodo | |
| BR112017007965A2 (pt) | método implantado por computador para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; aparelho para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; meio de armazenamento não transitório; programa de computador; kits para medir níveis de expressão de três ou mais genes-alvo da via de sinalização celular de tgf-b em uma amostra de um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; e uso do kit | |
| BR112014000965B8 (pt) | Método, aparelho e meio de armazenamento não transitório | |
| BR112015027643A2 (pt) | métodos e arranjos para permitir a continuação de medições de posicionamento contínuas na entrega | |
| BR112014032516A2 (pt) | método e dispositivo para processamento de imagem | |
| BR112014019090A8 (pt) | Método e aparelho | |
| NZ630026A (en) | Inhibition of the glycine cleavage system for treatment of cancer | |
| MX375171B (es) | Determinacion de las concentraciones de tensioactivo residual en el agua producida. | |
| UY34800A (es) | Combinaciones farmacéuticas que contienen un inhibidor de 11-beta-hidroxiesteroide dehidrogenasa-1 útil en trastornos metabólicos | |
| BR112017025864A2 (pt) | ?dispositivo para medir aspereza e brilho do cabelo, método para avaliar o estado do cabelo, kit e embalagem? | |
| BR112015025189A2 (pt) | aparelho de processamento e método de medir temperatura de peça de trabalho no aparelho de processamento | |
| NI201400042A (es) | 2 - tiopirimidinonas | |
| UY34193A (es) | Aparato para medir un objeto | |
| PE20151494A1 (es) | Proceso novedoso para la elaboracion de compuestos para su uso en el tratamiento del cancer | |
| CL2022001368A1 (es) | Uso de inhibidores de sglt-2 en el secado de mamíferos no humanos | |
| MX376685B (es) | Derivados de n-(1-hidroxi-3-(pirrolidinil)propan-2-il)pirrolidin-3-carboxamida como inhibidores de glucosilceramida sintasa. | |
| EA201401201A1 (ru) | Способ | |
| BR112017011903A2 (pt) | processo para avaliação do desempenho catalítico de um sólido poroso | |
| BR112014002406A2 (pt) | método para promoção de higiene e limpeza | |
| BR102012033267A2 (pt) | Dispositivo sensor | |
| PE20142297A1 (es) | Bioensayos con calidad controlada basados en celulas para productos nutriceuticos y medicinales | |
| MX2016015106A (es) | Derivados de dipicolilamina y sus usos farmaceuticos. | |
| UY35823A (es) | Profármacos de antagonista de nmda | |
| UY34455A (es) | Formulación oral compleja que comprende ácido graso omega 3 e inhibidor de la hmg-coa reductasa con estabilidad mejorada | |
| ES2529246T3 (es) | Inhibidores de microARN para usar en la prevención y/o atenuación del envejecimiento cutáneo y/o para hidratar la piel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |